Larimar Therapeutics
David Chu is an experienced marketing professional with a strong background in the pharmaceutical and healthcare sectors. As Executive Director of Marketing at Larimar Therapeutics Inc., David leads strategic marketing initiatives. Previously, David served as Senior Product Manager for Narcan Marketing at Adapt Pharma, focusing on promoting and positioning the product in the market. David also held the role of Product Manager for Interventional Vascular Marketing at BTG plc, where responsibilities included the development of marketing strategies for vascular products. Earlier in the career, David worked as a Consultant in Commercial Effectiveness Services at IMS Health, providing insights and strategies to enhance commercial performance.
This person is not in any teams
This person is not in any offices
Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease.